High prevalence of de novo metabolic dysfunction-associated fatty liver disease after liver transplantation and the role of controlled attenuation parameter

Table 1 Baseline parameters of patients with valid transient elastography after liver transplantation

Parameter	Value
Total valid scans (n) Scan age (years) Scan time from transplant (months) Male sex [n(%)] Transplant age (years) Body mass index at transplant (kg/m²) Body mass index at scan (kg/m²) *Transplant indication* Hepatitis B-related Hepatitis C-related Cryptogenic cirrhosis *Donor type* Deceased donor Living donor	549 59 (23–78) 77 (6-166) 395 (71.9%) 52 (19–73) 21.3 (13.2–35.8) 23.9 (15.0-39.4) 408 (74.3%) 36 (6.6%) 16 (2.9%) 260 (47.4%) 289 (52.6%)

ISSN: 1471-230X